M&A TRANSACTION · 2023
ProMedica Home Health / Hospice acquired by Gentiva
$710.0M· 7.9x EBITDA· 1.10x revenue
Target
ProMedica Home Health / Hospice
Acquirer
Gentiva
Strategic buyer
Disclosed financials at time of acquisition
Revenue
$672.9M
EBITDA
$90.0M
Deal Value
$710.0M
EV/EBITDA
7.9x
Context
This $710.0M acquisition of ProMedica Home Health / Hospice by Gentiva sits in the home health sub-vertical. The 7.9x EBITDA multiple paid in 2023 can be compared against the population median for home health transactions of similar size on our Home Health valuation hub. Gentiva is acquiring as a strategic buyer; see how strategic acquirers typically price home health businesses on our Home Health strategic buyer-pool page.
Source
Data sourced from Press releases, audited financial statements, press reporting. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology
Value your own home health
Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.
Compare your business to the ProMedica Home Health / Hospice acquisition.